NORTH CHICAGO, Ill., Jan. 12, 2015 -- The U.S. Food and Drug Administration (FDA) has approved AbbVie's (NYSE: ABBV) DUOPA™ (carbidopa and levodopa) enteral suspension for the treatment of motor ...
When you take medication by mouth, you feel its effects for as long as it’s circulating in your bloodstream and reaching its therapeutic target. Once drug levels in your bloodstream diminish, symptoms ...
DUOPA is the first and only treatment providing 16 continuous hours of carbidopa and levodopa for motor fluctuations in advanced Parkinson's disease · In a clinical trial, patients treated with DUOPA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results